A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma

被引：0
|
作者：
Zhen, Changqing [1 ]
Ding, Mei [1 ]
Lu, Kang [1 ]
Ge, Xueling [1 ]
Chen, Na
Fang, Xiaosheng [1 ]
Sui, Xiaohui [1 ]
Jiang Yujie [1 ]
Liu, Xin [1 ]
Li, Ying [1 ]
Wang, Xianghua [1 ]
Li, Ying [1 ]
Zhang, Lingyan [1 ]
Xu, Hongzhi [1 ]
Fan, Juan [1 ]
Wang, Xin [1 ]
机构：
[1] Shandong Univ, Dept Hematol, Shandong Prov Hosp, Jinan, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5323
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Safety of Bendamustine for the Treatment of Patients with B-Cell Non-Hodgkin Lymphoma, a Retrospective Cohort Study
    Cristaldo, Nancy
    Warley, Fernando
    Fantl, Dorotea
    Basquiera, Ana
    Otero, Victoria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S292 - S292
  • [42] Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma
    Zuckerman, E
    Zuckerman, T
    Levine, AM
    Douer, D
    Gutekunst, K
    Mizokami, M
    Qian, DG
    Velankar, M
    Nathwani, BN
    Fong, TL
    ANNALS OF INTERNAL MEDICINE, 1997, 127 (06) : 423 - 428
  • [43] Clinical Study on the Efficacy and Safety of Peg Rhg CSF for Autologous Hematopoietic Stem Cell Mobilization in Lymphoma and Multiple Myeloma:a Randomized Controlled, Multicenter Clinical Study
    Zhang, Lingqian
    Jun, Li
    Zhang, Wenjun
    Guo, Bingling
    Hu, Chongling
    Quan, Xi
    Zeng, Chensi
    Ding, Yao
    Huang, Dehong
    Xiao, Chunyan
    Liu, Jun
    Wu, Jing
    Wang, Chaoyu
    Liang, Xiping
    Yang, Zailin
    Liang, Shunsi
    Hu, Renzhi
    Liu, Tingting
    Li, Qiying
    Li, Jieping
    Nan, Yingyu
    Xiang, Ying
    Liu, Yao
    BLOOD, 2023, 142
  • [44] RITUXIMAB CLEARANCE IN PEDIATRIC PATIENTS WITH MAATURE B-CELL NON-HODGKIN LYMPHOMA
    Toelle, I.
    Lanvers-Kaminsky, C.
    Bethke, M.
    Randau, G.
    Rolfing, M.
    Tann, A.
    te Vrugt, M.
    Mellgren, K.
    Mueller, S.
    Burkhardt, B.
    LEUKEMIA RESEARCH, 2022, 121 : S23 - S24
  • [45] Cystatin C in sera of patients with aggressive non-Hodgkin B-cell lymphoma
    Softic, Adaleta
    Begic, Leila
    Halilbasic, Alma
    Kos, Janko
    MEDICINSKI GLASNIK, 2011, 8 (01) : 97 - 100
  • [46] Evaluation of cachexia and outcomes in patients with aggressive B-cell non-Hodgkin lymphoma
    Demetriou, Nicholas
    Burkart, Madelyn
    Sunderraj, Ashwin
    Ma, Shuo
    Winter, Jane N.
    Gordon, Leo I.
    Karmali, Reem
    Roy, Ishan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] PREDICTORS OF G-CSF PROPHYLAXIS IN THE FIRST CYCLE OF CHEMOTHERAPY FOR FEBRILE NEUTROPENIA IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA
    Lugtenburg, P.
    Asubonteng, J.
    DeCosta, L.
    Szabo, Z.
    Page, J. H.
    Wetten, S.
    HAEMATOLOGICA, 2014, 99 : 196 - 196
  • [48] Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study
    Gu, Yian
    Shore, Roy E.
    Arslan, Alan A.
    Koenig, Karen L.
    Liu, Mengling
    Ibrahim, Sherif
    Lokshin, Anna E.
    Zeleniuch-Jacquotte, Anne
    CANCER CAUSES & CONTROL, 2010, 21 (08) : 1323 - 1333
  • [49] Clinical Characteristics and Outcome of 104 Patients with Gastric Diffuse B-Cell Non-Hodgkin Lymphoma (DLBCL) a Multicenter Study
    Delamain, Marcia T.
    Martins Miranda, Eliana Cristina
    da Silva, Maria Gomes
    Desterro, Joana
    Francesco, Merli
    Chiattone, Carlos
    Luminari, Stefano
    Pagnano, Katia B. B.
    De Souza, Carmino Antonio
    Federico, Massimo
    BLOOD, 2015, 126 (23)
  • [50] A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma
    E Copelan
    B Pohlman
    L Rybicki
    M Kalaycio
    R Sobecks
    S Andresen
    R Dean
    A Koo
    J Chan
    J Sweetenham
    B Bolwell
    Bone Marrow Transplantation, 2009, 43 : 101 - 105
12345